(877) 505-4777| info@speakersnetwork.com


Assistant Professor of Hematology and Hematopoietic Cell Transplantation
City of Hope National Medical Center

Treatment for Graft-Versus-Host Disease
Bone Marrow Transplant

Alex Herrera, M.D. earned his undergraduate degree summa cum laude from Princeton University and received his medical degree from Harvard Medical School in Boston, MA. While in Boston, Dr. Herrera completed his residency in internal medicine at the Brigham and Women’s Hospital, before pursuing a hematology-oncology fellowship at the Dana-Farber Cancer Institute/Massachusetts General Hospital. Dr. Herrera is the recipient of several honors, grants, and awards including the American Society of Blood and Marrow Transplantation/Biology of Blood and Marrow Transplantation George Santos Award for Best Clinical Science Article by a New Investigator, American Society of Hematology Annual Meeting Abstract Achievement Award, and the American Society of Clinical Oncology/Conquer Cancer Foundation Young Investigator Award. He has published 21 articles in peer-reviewed publications, abstracts and book chapters, and has been invited to present his work nationally. Dr. Herrera was recently awarded the City of Hope K12 Paul Calabresi Career Development Award for Clinical Oncology.

Assistant Clinical Professor of Radiation Oncology
City of Hope National Medical Center

The Management of Metastatic Disease to the Central Nervous System
Contemporary Treatment for Head and Neck Malignancies
Evolution of the Treatment of Prostate Cancer
HPV, Cancer and Radiotherapy
Adjuvant Radiotherapy for Malignancies of the Breast
Paradigm Shift: Stereotactic Body Radiotherapy for the Treatment of Localized Cancer


Chief, Pediatric Community Outreach Program
Assistant Professor of Pediatrics
City of Hope National Medical Center

Treatment of Rare and Solid Tumors
Community-Based Pediatric Hematology / Oncology
Neural Tumors including Neuroblastoma and Brain Tumor
Developmental Therapeutics in Neuroblastoma


Professor of Oncology
Department of Medical Oncology and Experimental Therapeutics & Molecular and Cellular Biology
City of Hope National Medical Center

Treatment of Advanced Prostate Cancer
Oligonucleotide Therapeutics


Assistant Clinical Professor of Medical Oncology and Therapeutics Research
City of Hope National Medical Center

Challenges in Caring for Older Adults with Hepatobiliary Malignancies
Systemic Therapies for Neuroendocrine Tumors


Assistant Professor of Medicine
Vanderbilt University Medical Center

Immune Checkpoint Inhibitors


Associate Clinical Professor of Medical Oncology and Therapeutics Research
City of Hope National Medical Center

Lung Cancer Update
Update on Head and Neck Cancers


Professor and Chairman of Radiation Oncology
University of Texas Southwestern Medical Center

Combined Modality Therapy in Non-Small Cell Lung Cancer: Past, Present, Future
New Developments in Chemo-Radiation

n the course of more than 30 years as a radiation oncologist, Hak Choy, M.D., has worked with almost every new compound that has been developed to combine with radiation, and has distinguished himself as a world-leading expert in chemoradiation therapy. Dr. Choy is Professor and Chair of the Department of Radiation Oncology at UT Southwestern and holds the Nancy B. and Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research. He graduated from the University of Texas Medical Branch in Galveston and completed a residency in internal medicine/radiation oncology at Ohio State, as well as a residency in radiation oncology at the University of Texas Health Science Center in San Antonio. Dr. Choy is board certified in therapeutic radiology and was Professor and Vice Chair of the Department of Radiation Oncology at Vanderbilt University before joining UT Southwestern as department chair in 2003. He has been the prime motivator in growing UT Southwestern’s radiation oncology practice to the region’s largest, with two campus locations, including one that opened in 2011. Dr. Choy is active in the clinic, where he treats patients presenting with small cell lung cancer, non-small cell lung cancer, and metastases of lung cancer to other sites. He continues to be a lead investigator of clinical trials offering new combinations of treatments to patients. Dr. Choy currently serves as Chair of the Data Safety Monitoring Board and Vice Chair of the Executive Committee of the Radiation Therapy Oncology Group (RTOG). He is also a member of the board of directors of the International Association for the Study of Lung Cancer (IASLC). He is a member of the board of directors of UT Southwestern Health Systems and sits on several other institutional committees. He is a member of the editorial board of Cancer Research and Treatment, Clinical Lung Cancer, and other scientific publications, and he has served as reviewer for the New England Journal of Medicine and many others. Dr. Choy holds a patent for the radio-enhanced delivery of camptothecin-derivative drugs for cancer treatment.

Medical Director, Duarte Clinics
Clinical Professor of Medical Oncology & Therapeutics Research
City of Hope National Medical Center

What Are My Risks for Developing Breast Cancer?
Implementing Survivorship Care in Breast Cancer Patients
Breast Cancer Vaccine Development: A Collaboration and a Vision
Metastatic Breast Cancer


Director, T Cell Lymphoma Program
Associate Professor, Hematology & HCT
City of Hope National Medical Center

Cutaneous T-Cell Lymphoma